(Q40484723)

English

Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

piperacillin/tazobactam

1 reference

based on heuristic

inferred from title

author name string

Funda Corapcioglu

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Nazan Sarper

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Emine Zengin

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

publication date

1 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Pediatric Hematology and Oncology

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

177-186

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506370

21 January 2018

Empirical antibiotic therapy in neutropenic cancer patients.

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506370

21 January 2018

Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506370

21 January 2018

Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer).

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506370

21 January 2018

Is monotherapy for febrile neutropenia still a viable alternative?

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506370

21 January 2018

Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506370

21 January 2018

Cefepime versus ceftazidime + amikacin as empirical therapy for febrile neutropenia in children with cancer: a prospective randomized trial of the treatment efficacy and cost

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506370

21 January 2018

Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506370

21 January 2018

Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Tre

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506370

21 January 2018

A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506370

21 January 2018

Piperacillin-tazobactam and netilmicin as a safe and efficacious empirical treatment of febrile neutropenic children

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506370

21 January 2018

Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506370

21 January 2018

Cefepime vs. Meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506370

21 January 2018

Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506370

21 January 2018

An open, multicenter clinical trial of piperacillin/tazobactam in the treatment of pediatric patients with intra-abdominal infections.

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506370

21 January 2018

Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506370

21 January 2018

Piperacillin/tazobactam plus gentamicin as empirical therapy for febrile neutropenic patients with haematological malignancy

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506370

21 January 2018

Single-dose pharmacokinetics of piperacillin and tazobactam in infants and children

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506370

21 January 2018

Tolerability of piperacillin/tazobactam in children and adolescents after high dose radio-/chemotherapy and autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506370

21 January 2018

Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey

1 reference

https://api.crossref.org/works/10.1080%2F08880010500506370

21 January 2018

Identifiers

10.1080/08880010500506370

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40484723&oldid=1898086453"